Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to evaluate the safety profile and tolerability of single oral doses of BMS-791325 in subjects with chronic hepatitis C infection
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06180590 · Chronic Hepatitis C, Medication Reaction
NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage
NCT00199719 · Chronic Hepatitis C
NCT06922643 · Chronic Hepatitis C
NCT01340573 · Chronic Hepatitis C
Advanced Clinical Res Inst
Anaheim, California
West Coast Clinical Trials, Llc
Cypress, California
Washington University School Of Medicine
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions